_id
6911bd57ccc777a4e85d6260
Ticker
GLTO
Name
Galecto Inc
Exchange
NASDAQ
Address
Ole Maaloes Vej 3, Copenhagen, Denmark, 2200
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://galecto.com
Description
Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
Last Close
29.01
Volume
39056
Current Price
32
Change
10.306790761806267
Last Updated
2025-11-30T19:25:47.858Z
Image
data:image/webp;base64,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
Ipo Date
2020-10-29T00:00:00.000Z
Market Cap
28315024
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.99
Sentiment Sources
2
Rating
4
Target Price
6
Strong Buy
1
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
3156000
Operating Income
-3156000
Interest Expense
-
Pretax Income
-3133000
Net Income
-3133000
Eps
-2.3608951959965006
Dividends Per Share
-
Shares Outstanding
1592521
Income Tax Expense
-
EBITDA
-3123000
Operating Margin
-
Total Other Income Expense Net
23000
Cash
7606000
Short Term Investments
-
Receivables
992000
Inventories
-
Total Current Assets
9786000
Property Plant Equipment
113000
Total Assets
10736000
Payables
520000
Short Term Debt
15000
Long Term Debt
-
Total Liabilities
4070000
Equity
6666000
Depreciation
10000
Change In Working Capital
332000
Cash From Operations
-2616000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-2605000
PE
-
PB
6.370424242424243
ROE
-46.999699969996996
ROA
-29.182190760059612
FCF
-2616000
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
3
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
3
Quality Investing Score
2
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
3156000
Quarters > 0 > income Statement > operating Income
-3156000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-3133000
Quarters > 0 > income Statement > net Income
-3133000
Quarters > 0 > income Statement > eps
-2.3608951959965006
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1327039
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3123000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
23000
Quarters > 0 > balance Sheet > cash
7606000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
992000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
9786000
Quarters > 0 > balance Sheet > property Plant Equipment
113000
Quarters > 0 > balance Sheet > total Assets
10736000
Quarters > 0 > balance Sheet > payables
520000
Quarters > 0 > balance Sheet > short Term Debt
15000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4070000
Quarters > 0 > balance Sheet > equity
6666000
Quarters > 0 > cash Flow > net Income
-3133000
Quarters > 0 > cash Flow > depreciation
10000
Quarters > 0 > cash Flow > change In Working Capital
332000
Quarters > 0 > cash Flow > cash From Operations
-2616000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-2605000
Quarters > 0 > ratios > PE
-2.3608951959965006
Quarters > 0 > ratios > PB
6.370424242424243
Quarters > 0 > ratios > ROE
-46.999699969996996
Quarters > 0 > ratios > ROA
-29.182190760059612
Quarters > 0 > ratios > FCF
-2616000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
9000
Quarters > 1 > income Statement > gross Profit
-9000
Quarters > 1 > income Statement > operating Expenses
3421000
Quarters > 1 > income Statement > operating Income
-3421000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-3433000
Quarters > 1 > income Statement > net Income
-3437000
Quarters > 1 > income Statement > eps
-2.598761637529838
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1322553
Quarters > 1 > income Statement > income Tax Expense
4000
Quarters > 1 > income Statement > EBITDA
-3412000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-12000
Quarters > 1 > balance Sheet > cash
10211000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
988000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
13027000
Quarters > 1 > balance Sheet > property Plant Equipment
122000
Quarters > 1 > balance Sheet > total Assets
13691000
Quarters > 1 > balance Sheet > payables
756000
Quarters > 1 > balance Sheet > short Term Debt
15000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2738000
Quarters > 1 > balance Sheet > equity
10953000
Quarters > 1 > cash Flow > net Income
-3437000
Quarters > 1 > cash Flow > depreciation
9000
Quarters > 1 > cash Flow > change In Working Capital
1017000
Quarters > 1 > cash Flow > cash From Operations
-2237000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-1728000
Quarters > 1 > ratios > PE
-2.598761637529838
Quarters > 1 > ratios > PB
3.863936455765544
Quarters > 1 > ratios > ROE
-31.379530722176575
Quarters > 1 > ratios > ROA
-25.10408297421664
Quarters > 1 > ratios > FCF
-2237000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
2599000
Quarters > 2 > income Statement > operating Income
-2599000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2531000
Quarters > 2 > income Statement > net Income
-2533000
Quarters > 2 > income Statement > eps
-1.9160203659424921
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1322011
Quarters > 2 > income Statement > income Tax Expense
2000
Quarters > 2 > income Statement > EBITDA
-2591000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
68000
Quarters > 2 > balance Sheet > cash
11939000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
917000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
14923000
Quarters > 2 > balance Sheet > property Plant Equipment
125000
Quarters > 2 > balance Sheet > total Assets
15365000
Quarters > 2 > balance Sheet > payables
354000
Quarters > 2 > balance Sheet > short Term Debt
13000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1656000
Quarters > 2 > balance Sheet > equity
13709000
Quarters > 2 > cash Flow > net Income
-2533000
Quarters > 2 > cash Flow > depreciation
8000
Quarters > 2 > cash Flow > change In Working Capital
-123000
Quarters > 2 > cash Flow > cash From Operations
-2439000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-2236000
Quarters > 2 > ratios > PE
-1.9160203659424921
Quarters > 2 > ratios > PB
3.0858816835655407
Quarters > 2 > ratios > ROE
-18.476912976876505
Quarters > 2 > ratios > ROA
-16.485519036771883
Quarters > 2 > ratios > FCF
-2439000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
5000
Quarters > 3 > income Statement > gross Profit
-5000
Quarters > 3 > income Statement > operating Expenses
2702000
Quarters > 3 > income Statement > operating Income
-2707000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-6749000
Quarters > 3 > income Statement > net Income
-6741000
Quarters > 3 > income Statement > eps
-5.825524629930977
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1157149
Quarters > 3 > income Statement > income Tax Expense
-8000
Quarters > 3 > income Statement > EBITDA
-6744000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-4042000
Quarters > 3 > balance Sheet > cash
14175000
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
881000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
16839000
Quarters > 3 > balance Sheet > property Plant Equipment
130000
Quarters > 3 > balance Sheet > total Assets
17132000
Quarters > 3 > balance Sheet > payables
377000
Quarters > 3 > balance Sheet > short Term Debt
12000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1301000
Quarters > 3 > balance Sheet > equity
15831000
Quarters > 3 > cash Flow > net Income
-6741000
Quarters > 3 > cash Flow > depreciation
-54000
Quarters > 3 > cash Flow > change In Working Capital
-347000
Quarters > 3 > cash Flow > cash From Operations
-4936000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-5503000
Quarters > 3 > ratios > PE
-5.825524629930977
Quarters > 3 > ratios > PB
2.3390037268650117
Quarters > 3 > ratios > ROE
-42.58101193860148
Quarters > 3 > ratios > ROA
-39.34742003268737
Quarters > 3 > ratios > FCF
-4936000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
4395000
Annuals > 0 > income Statement > gross Profit
-4395000
Annuals > 0 > income Statement > operating Expenses
22260000
Annuals > 0 > income Statement > operating Income
-22260000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-21398000
Annuals > 0 > income Statement > net Income
-21439000
Annuals > 0 > income Statement > eps
-18.52743250869162
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1157149
Annuals > 0 > income Statement > income Tax Expense
41000
Annuals > 0 > income Statement > EBITDA
-21111000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
862000
Annuals > 0 > balance Sheet > cash
14175000
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
881000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
16839000
Annuals > 0 > balance Sheet > property Plant Equipment
130000
Annuals > 0 > balance Sheet > total Assets
17132000
Annuals > 0 > balance Sheet > payables
377000
Annuals > 0 > balance Sheet > short Term Debt
12000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1301000
Annuals > 0 > balance Sheet > equity
15831000
Annuals > 0 > cash Flow > net Income
-21439000
Annuals > 0 > cash Flow > depreciation
181000
Annuals > 0 > cash Flow > change In Working Capital
-2667000
Annuals > 0 > cash Flow > cash From Operations
-18623000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
11650000
Annuals > 0 > cash Flow > cash From Financing
0
Annuals > 0 > cash Flow > net Change In Cash
-7290000
Annuals > 0 > ratios > PE
-18.52743250869162
Annuals > 0 > ratios > PB
1.2996089457393722
Annuals > 0 > ratios > ROE
-135.42416777209272
Annuals > 0 > ratios > ROA
-125.1400887228578
Annuals > 0 > ratios > FCF
-18623000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
830000
Annuals > 1 > income Statement > gross Profit
-830000
Annuals > 1 > income Statement > operating Expenses
39905000
Annuals > 1 > income Statement > operating Income
-39905000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-38349000
Annuals > 1 > income Statement > net Income
-38349000
Annuals > 1 > income Statement > eps
-36.0805779817118
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1062871
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-35627000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
1556000
Annuals > 1 > balance Sheet > cash
21465000
Annuals > 1 > balance Sheet > short Term Investments
11686000
Annuals > 1 > balance Sheet > receivables
1718000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
36774000
Annuals > 1 > balance Sheet > property Plant Equipment
325000
Annuals > 1 > balance Sheet > total Assets
38227000
Annuals > 1 > balance Sheet > payables
1702000
Annuals > 1 > balance Sheet > short Term Debt
183000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5896000
Annuals > 1 > balance Sheet > equity
32331000
Annuals > 1 > cash Flow > net Income
-38349000
Annuals > 1 > cash Flow > depreciation
830000
Annuals > 1 > cash Flow > change In Working Capital
-4370000
Annuals > 1 > cash Flow > cash From Operations
-36911000
Annuals > 1 > cash Flow > capital Expenditures
83000
Annuals > 1 > cash Flow > cash From Investing
22330000
Annuals > 1 > cash Flow > cash From Financing
2876000
Annuals > 1 > cash Flow > net Change In Cash
-11321000
Annuals > 1 > ratios > PE
-36.0805779817118
Annuals > 1 > ratios > PB
0.5845116569236956
Annuals > 1 > ratios > ROE
-118.61371439176023
Annuals > 1 > ratios > ROA
-100.31914615324247
Annuals > 1 > ratios > FCF
-36994000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
490000
Annuals > 2 > income Statement > gross Profit
-490000
Annuals > 2 > income Statement > operating Expenses
61207000
Annuals > 2 > income Statement > operating Income
-61207000
Annuals > 2 > income Statement > interest Expense
417000
Annuals > 2 > income Statement > pretax Income
-61624000
Annuals > 2 > income Statement > net Income
-61624000
Annuals > 2 > income Statement > eps
-60.63182088306945
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1016364
Annuals > 2 > income Statement > income Tax Expense
417000
Annuals > 2 > income Statement > EBITDA
-60717000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-417000
Annuals > 2 > balance Sheet > cash
32786000
Annuals > 2 > balance Sheet > short Term Investments
27438000
Annuals > 2 > balance Sheet > receivables
1379000
Annuals > 2 > balance Sheet > inventories
2255000
Annuals > 2 > balance Sheet > total Current Assets
63910000
Annuals > 2 > balance Sheet > property Plant Equipment
1167000
Annuals > 2 > balance Sheet > total Assets
73188000
Annuals > 2 > balance Sheet > payables
3350000
Annuals > 2 > balance Sheet > short Term Debt
476000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
11435000
Annuals > 2 > balance Sheet > equity
61753000
Annuals > 2 > cash Flow > net Income
-61624000
Annuals > 2 > cash Flow > depreciation
490000
Annuals > 2 > cash Flow > change In Working Capital
11937000
Annuals > 2 > cash Flow > cash From Operations
-42932000
Annuals > 2 > cash Flow > capital Expenditures
196000
Annuals > 2 > cash Flow > cash From Investing
12384000
Annuals > 2 > cash Flow > cash From Financing
507000
Annuals > 2 > cash Flow > net Change In Cash
-29777000
Annuals > 2 > ratios > PE
-60.63182088306945
Annuals > 2 > ratios > PB
0.29263277767881724
Annuals > 2 > ratios > ROE
-99.79110326623808
Annuals > 2 > ratios > ROA
-84.199595562114
Annuals > 2 > ratios > FCF
-43128000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
441000
Annuals > 3 > income Statement > gross Profit
-441000
Annuals > 3 > income Statement > operating Expenses
52227000
Annuals > 3 > income Statement > operating Income
-52227000
Annuals > 3 > income Statement > interest Expense
475000
Annuals > 3 > income Statement > pretax Income
-51752000
Annuals > 3 > income Statement > net Income
-51752000
Annuals > 3 > income Statement > eps
-51.21561882405567
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1010473
Annuals > 3 > income Statement > income Tax Expense
-475000
Annuals > 3 > income Statement > EBITDA
-51786000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
475000
Annuals > 3 > balance Sheet > cash
62563000
Annuals > 3 > balance Sheet > short Term Investments
37628000
Annuals > 3 > balance Sheet > receivables
2280000
Annuals > 3 > balance Sheet > inventories
7297000
Annuals > 3 > balance Sheet > total Current Assets
110102000
Annuals > 3 > balance Sheet > property Plant Equipment
1037000
Annuals > 3 > balance Sheet > total Assets
122215000
Annuals > 3 > balance Sheet > payables
1531000
Annuals > 3 > balance Sheet > short Term Debt
399000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
4992000
Annuals > 3 > balance Sheet > equity
117223000
Annuals > 3 > cash Flow > net Income
-51752000
Annuals > 3 > cash Flow > depreciation
441000
Annuals > 3 > cash Flow > change In Working Capital
-6624000
Annuals > 3 > cash Flow > cash From Operations
-52308000
Annuals > 3 > cash Flow > capital Expenditures
223000
Annuals > 3 > cash Flow > cash From Investing
-48048000
Annuals > 3 > cash Flow > cash From Financing
507000
Annuals > 3 > cash Flow > net Change In Cash
-101273000
Annuals > 3 > ratios > PE
-51.21561882405567
Annuals > 3 > ratios > PB
0.1532652290079592
Annuals > 3 > ratios > ROE
-44.148332665091324
Annuals > 3 > ratios > ROA
-42.345047661907294
Annuals > 3 > ratios > FCF
-52531000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-2.3608951959965006
Valuation > metrics > PB
6.370424242424243
Valuation > final Score
20
Valuation > verdict
112.3% Overvalued
Profitability > metrics > ROE
-46.999699969996996
Profitability > metrics > ROA
-32.01512364602493
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6105610561056105
Risk > metrics > Interest Coverage
-315.6
Risk > final Score
-1214
Risk > verdict
High
Liquidity > metrics > Current Ratio
18.29158878504673
Liquidity > metrics > Quick Ratio
18.29158878504673
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
41.36063544234456
Prev Valuations > 1
49.141183164344596
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-592
Prev Risks > 1
-113
Prev Risks > 2
-2106
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:33:23.560Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-07
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-2.3609
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-11
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-2.6
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-2.6
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-28
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-1.916
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-19
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-5
Earnings History > 3 > eps Estimate
-2.82
Earnings History > 3 > eps Difference
-2.18
Earnings History > 3 > surprise Percent
-77.305
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-01
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-3.39
Earnings History > 4 > eps Estimate
-3.7
Earnings History > 4 > eps Difference
0.31
Earnings History > 4 > surprise Percent
8.3784
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-05
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.16
Earnings History > 5 > eps Estimate
-0.31
Earnings History > 5 > eps Difference
0.15
Earnings History > 5 > surprise Percent
48.3871
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-04-29
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2
Earnings History > 6 > eps Estimate
-0.41
Earnings History > 6 > eps Difference
0.21
Earnings History > 6 > surprise Percent
51.2195
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-08
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.24
Earnings History > 7 > eps Estimate
-0.31
Earnings History > 7 > eps Difference
0.07
Earnings History > 7 > surprise Percent
22.5806
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-06
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.3
Earnings History > 8 > eps Estimate
-0.47
Earnings History > 8 > eps Difference
0.17
Earnings History > 8 > surprise Percent
36.1702
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-07-31
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.41
Earnings History > 9 > eps Estimate
-0.59
Earnings History > 9 > eps Difference
0.18
Earnings History > 9 > surprise Percent
30.5085
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-04-28
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.51
Earnings History > 10 > eps Estimate
-0.62
Earnings History > 10 > eps Difference
0.11
Earnings History > 10 > surprise Percent
17.7419
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-09
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.55
Earnings History > 11 > eps Estimate
-0.57
Earnings History > 11 > eps Difference
0.02
Earnings History > 11 > surprise Percent
3.5088
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.54
Earnings History > 12 > eps Estimate
-0.68
Earnings History > 12 > eps Difference
0.14
Earnings History > 12 > surprise Percent
20.5882
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-07-29
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.67
Earnings History > 13 > eps Estimate
-0.69
Earnings History > 13 > eps Difference
0.02
Earnings History > 13 > surprise Percent
2.8986
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-04-29
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.67
Earnings History > 14 > eps Estimate
-0.61
Earnings History > 14 > eps Difference
-0.06
Earnings History > 14 > surprise Percent
-9.8361
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-17
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.53
Earnings History > 15 > eps Estimate
-0.56
Earnings History > 15 > eps Difference
0.03
Earnings History > 15 > surprise Percent
5.3571
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-04
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.5
Earnings History > 16 > eps Estimate
-0.56
Earnings History > 16 > eps Difference
0.06
Earnings History > 16 > surprise Percent
10.7143
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-05
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.49
Earnings History > 17 > eps Estimate
-0.54
Earnings History > 17 > eps Difference
0.05
Earnings History > 17 > surprise Percent
9.2593
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-04
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.53
Earnings History > 18 > eps Estimate
-0.46
Earnings History > 18 > eps Difference
-0.07
Earnings History > 18 > surprise Percent
-15.2174
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-29
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.47
Earnings History > 19 > eps Estimate
-0.91
Earnings History > 19 > eps Difference
0.44
Earnings History > 19 > surprise Percent
48.3516
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-11
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-55.25
Earnings History > 20 > eps Estimate
-0.59
Earnings History > 20 > eps Difference
-54.66
Earnings History > 20 > surprise Percent
-9264.4068
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-02
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-44.66
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-44.66
Earnings History > 21 > surprise Percent
-
Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGalecto (NASDAQ:GLTO) Price Target Raised to $36.00 at Guggenheim Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$6
Analyst Picks
Strong Buy
1
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 11.48% of the total shares of Galecto Inc
1.
Novo A/S(7.5431%)
since
2025/06/30
2.
Renaissance Technologies Corp(1.098%)
since
2025/06/30
3.
Susquehanna International Group, LLP(1.0269%)
since
2025/06/30
4.
Vanguard Institutional Extnd Mkt Idx Tr(0.4413%)
since
2025/07/31
5.
Fidelity Extended Market Index(0.3915%)
since
2025/07/31
6.
Fidelity Total Market Index(0.1852%)
since
2025/07/31
7.
UBS Group AG(0.1746%)
since
2025/06/30
8.
Fidelity Series Total Market Index(0.1245%)
since
2025/07/31
9.
Bank of America Corp(0.0927%)
since
2025/06/30
10.
NT Ext Equity Mkt Idx Fd - L(0.0836%)
since
2025/06/30
11.
Northern Trust Extended Eq Market Idx(0.0836%)
since
2025/06/30
12.
Tower Research Capital LLC(0.0711%)
since
2025/06/30
13.
Vanguard U.S. Eq Idx £ Acc(0.0257%)
since
2025/07/31
14.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0236%)
since
2025/06/30
15.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0199%)
since
2024/12/31
16.
NT Ext Equity Mkt Idx Fd - NL(0.0195%)
since
2025/06/30
17.
Spartan Total Market Index Pool G(0.0189%)
since
2025/07/31
18.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0151%)
since
2025/06/30
19.
BlackRock Inc(0.0075%)
since
2025/06/30
20.
Barclays PLC(0.0075%)
since
2025/06/30
21.
State St US Extended Mkt Indx NL Cl C(0.0061%)
since
2025/08/31
22.
State St US Ttl Mkt Indx NL Cl A(0.0057%)
since
2025/08/31
23.
Northern Trust Wilshire 5000(0.0047%)
since
2025/06/30
24.
Spartan Extended Market Index Pool F(0.0028%)
since
2025/07/31
25.
SSgA U.S. Total Market Index Strategy(0.0026%)
since
2025/03/31
26.
SBI Securities Co Ltd(0.0014%)
since
2025/06/30
27.
Fidelity U.S. Equity Index Ins Trust(0.0005%)
since
2025/07/31
28.
Group One Trading, LP(0%)
since
2025/06/30
29.
Morgan Stanley - Brokerage Accounts(0%)
since
2025/03/31
30.
JPMorgan Chase & Co(0%)
since
2025/03/31
31.
Squarepoint Ops LLC(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-2.3609
EPS Estimate
—
EPS Difference
0
Surprise Percent
null%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.